Events
-
-
Postdoc Position – Investigator, Medicinal Chemistry
gsk 1250 S Collegeville Rd, Collegeville, PA, United StatesBasic qualifications: • PhD degree in Organic Chemistry, or Medicinal Chemistry. • 0 to 3 years of professional and/or industrial experience. • High level of synthetic chemistry expertise allowing one to plan synthetic routes to, and prepare molecules of interest to advance lead optimization efforts. • Well versed in the application of new synthetic methodology. [...]
-
-
VP Head of Experimental Medicine Unit
gsk 1250 S Collegeville Rd, Collegeville, PA, United StatesBasic qualifications: • M.D., PhD, or MD/PhD degree • 10 years pharmaceutical or relevant medical/clinical experience • Keen understanding of translational medicine and its role in drug development • Experience with translational investigation of cell-based therapy, cancer immunotherapies and/or cancer epigenetics modifiers is a plus. • Relevant experience in translational medicine, companion diagnosis, and early [...]
-
Medical Director, Clinical Development
gsk 1250 S Collegeville Rd, Collegeville, PA, United StatesBasic qualifications: • M.D. degree with sub-specialty in Oncology and clinical development experience is highly preferred • 5 years pharmaceutical or relevant medical/clinical experience • Keen understanding of drug development • Experience with clinical and translational investigation of cell-based therapy, cancer immunotherapies and/or cancer epigenetics modifiers is a plus. • Relevant experience in early phase [...]
-
Global Medical Affairs Leader – Oncology (Cell Therapy)
gsk 1250 S Collegeville Rd, Collegeville, PA, United StatesBasic qualifications: • Medical Doctor with Oncology specialist training or Board Certified Oncologist. • Proven Global Medical Affairs leadership experience in LOC and above country roles. • Deep knowledge and expertise within Oncology. • Experience with Pre-Launch activities. • Strong collaboration and partnering skills. • Demonstrable cross functional matrix leadership skills. • Strong stance on [...]